Estonia - Lipid Modifying Medicine Use
Since 2014, Estonia Lipid Modifying Medicine Use rose 7.9% year on year. With 69.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 26 comparing other countries in Lipid Modifying Medicine Use. Estonia is overtaken by South Korea, which was ranked number 25 at 74.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Lithuania at 46.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +3.5% versus 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia witnessed the worst performance at -8.7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 69.10 |
| 2018 | 64.40 |
| 2017 | 58.20 |
| 2016 | 53.40 |
| 2015 | 51.60 |
How does Estonia rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 25 |
#25
South Korea
|
74 | 2019 | +2.4 % | +7.3 % | View data | |
| 26 |
#26
Estonia
|
69 | 2019 | +7.3 % | +7.9 % | View data | |
| 27 |
#27
Lithuania
|
47 | 2019 | +0.2 % | +18.8 % | View data | |